All stock reports

DIVISLAB evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-06T04:32:35.767073+00:00

Metrics

latest_annual_period
2026-03-31
revenue
105600000000.0
net_income
25680000000.0
operating_cash_flow
30170000000.0
free_cash_flow
4970000000.0
total_assets
200330000000.0
total_liabilities
32720000000.0
total_equity
167610000000.0
cash
1280000000.0
total_debt
70000000.0
revenue_growth
0.13243967828418235
earnings_growth
0.17206754906435417
net_margin
0.2431818181818182
roe
0.1532128154644711
debt_to_equity
0.0004176361792255832
cash_conversion
1.1748442367601246
free_cash_flow_margin
0.04706439393939394
trailing_pe
85.7261
forward_pe
19.5695
peg_ratio
Not supplied
price_to_book
13.1063
dividend_yield
0.0

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Trend Continuation Pullback

Research only. Direction: LONG.

Tests continuation after a controlled retracement within an established trend

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Price breach below slow EMA
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-232cc144c243e630c4658f7dbca2d6d03d7dce9e6e84c8e6ad72439632463666
Policy
stock-decisions-v1
Evidence bundle hash
1430d5b8c28087f50e419730f0e8302bdacb98a972672a8f89ce52d6485ac43e
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: d4e5595523ea4c125ba53ca77c87d09f799c0ce9987d6660b5504552825e0817
  • daily-price: 6ad0e5e3fe2a0cc5e05328778b3ebfada0d58d005760a855bf813dd9e0aea95d
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 5-session price return was -3.68%. The trailing 20-session price return was 0.31%. The trailing 60-session price return was 37.49%. The trailing 250-session price return was 57.49%. Average cached traded value over twenty sessions was INR 4,756,148,299.

Risks

The closing price was -3.90% below its highest close in the available trailing year. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.13243967828418235. The cached financial metric net margin is 0.2431818181818182. The cached financial metric roe is 0.1532128154644711. The cached financial metric debt to equity is 0.0004176361792255832. The cached financial metric cash conversion is 1.1748442367601246.

Cached observations and evidence limits